Ignite Creation Date:
2024-05-06 @ 1:54 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04150042
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2019-10-30
Brief Title:
SHARON A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients Own Stem Cells
Sponsor:
General Oncology Inc
Organization:
General Oncology Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| PALB2 Gene Mutation |
| Pancreatic Adenocarcinoma Metastatic |
| BRCA1 Mutation |
| BRCA2 Mutation |
| Pancreatic Acinar Cell Carcinoma |
| Pancreatic Ductal Adenocarcinoma |
| Pancreatic Cancer |
| Metastatic Pancreatic Cancer |
| Metastatic Pancreatic Ductal Adenocarcinoma |
| Breast Cancer Metastatic |
| Breast Cancer Stage IV |
| Pancreatic Cancer Stage IV |
| HER2-negative Breast Cancer |
| HER2 Negative Breast Carcinoma |
| Adenocarcinoma of the Breast |
Keywords:
| Name | View |
|---|---|
| metastatic breast cancer | View |
| pancreatic adenocarcinoma | View |
| pancreatic cancer | View |
| BRCA | View |
| BRCA1 | View |
| BRCA2 | View |
| melphalan | View |
| BCNU | View |
| carmustine | View |
| vitamin C | View |
| vitamin B12b | View |
| autologous stem cell infusion | View |
| stage 4 pancreatic cancer | View |
| metastatic pancreatic cancer | View |
| pancreatic acinar cell carcinoma | View |
| pancreatic ductal adenocarcinoma | View |
| PDAC | View |
| breast cancer | View |
| stage 4 breast cancer | View |
| stage IV pancreatic cancer | View |
| stage IV breast cancer | View |
| stem cells | View |
| HER2-negative breast cancer | View |
| PALB2 | View |